Survival implications of systemic immunosuppression timing, dosage, and duration in immune checkpoint inhibitor therapy: A retrospective multicohort study
Charles Lu
Pro |
Presented at: Society for Investigative Dermatology 2025
Date: 2025-05-07 00:00:00
Views: 21
Summary: Content is hidden. So this is just placeholder text should someone try to view the source of the content. You thought you could get away with it, didn't you? Now look at you just continuing to scroll. Have a great day!